Hepatitis D virus infection
MONDO:0005789Inflammation of the liver in humans caused by hepatitis delta virus, a defective RNA virus that can only infect hepatitis B patients. For its viral coating, hepatitis delta virus requires the hepatitis B surface antigens produced by these patients. Hepatitis D can occur either concomitantly with (coinfection) or subsequent to (superinfection) hepatitis B infection. Similar to hepatitis B, it is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.
Also known as: HDV, Hepatitis D, Hepatitis D virus, Hepatitis delta virus caused hepatitis, Hepatitis delta virus hepatitis, hepatitis delta, hepatitis type D
52 clinical trials for this condition and its sub-types, 47 tagged with Hepatitis D virus infection itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
New drug bulevirtide tracked in real-world hepatitis d patients
Disease control Stopped earlyThis study follows 170 people with chronic hepatitis D who are taking bulevirtide to see how well it works over time and what side effects may occur. Researchers will track serious liver problems like liver failure, cancer, or need for transplant. The goal is to understand the dr…
Sponsor: Gilead Sciences • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Experimental hepatitis b drug shows promise in early trial
Disease control Stopped earlyThis study tested a new drug called ARC-520 in 79 people with chronic hepatitis B. Some participants received ARC-520 alone, while others got it combined with standard treatments like entecavir or tenofovir. The goal was to see if ARC-520 could lower hepatitis B surface antigen l…
Phase 2 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Hepatitis b patients under the microscope: new study observes Real-World treatments
Knowledge-focused Stopped earlyThis study observed over 1,700 adults with chronic hepatitis B in the US and Canada to understand how the disease progresses and how treatments are used in everyday medical practice. Researchers collected data from both academic and community clinics to build a real-world picture…
Sponsor: Target PharmaSolutions, Inc. • Aim: Knowledge-focused
Last updated Jun 26, 2026 18:05 UTC